# Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

> **NCT01891123** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 300 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Breast Cancer
- Nasal Cancer

## Interventions

- **DEVICE:** PK guided arm
- **DRUG:** PTX 175mg/m2, DOC 75mg/m2

## Key facts

- **NCT ID:** NCT01891123
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891123, "Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01891123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*